FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:93-96 July 7, 2005 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Pitt, B. Related Article by LaRosa, J. C. PubMed Citation

To the Editor: LaRosa and colleagues (April 7 issue)¹ report that among patients with stable coronary heart disease (CHD), an intensive statin regimen provides a 22 percent reduction in the risk of cardiovascular events when compared with a standard regimen. However, despite the 20 percent reduction in the risk of death from CHD in the group that received 80 mg of atorvastatin per day, there was no significant difference between the groups in overall mortality. This finding reflects an increase in the risk of death from noncardiovascular causes, which is undoubtedly a matter of concern.

In patients with an acute . . . [Full Text of this Article]

This article has been cited by other articles:

• Niessen, J., Jedlitschky, G., Grube, M., Bien, S., Schwertz, H., Ohtsuki, S., Kawakami, H., Kamiie, J., Oswald, S., Starke, K., Strobel, U., Siegmund, W., Rosskopf, D., Greinacher, A., Terasaki, T., Kroemer, H. K. (2009). Human Platelets Express Organic Anion-Transporting Peptide 2B1, an Uptake Transporter for Atorvastatin. Drug Metab. Dispos. 37: 1129-1137 [Abstract] [Full Text]  
• SHISHEHBOR, M. H., HAZEN, S. L. (2009). JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?. Cleveland Clinic Journal of Medicine 76: 37-44 [Abstract] [Full Text]  
• Patel, T. N., Shishehbor, M. H., Bhatt, D. L. (2007). A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis. Eur Heart J 28: 664-672 [Abstract] [Full Text]  
• Belay, B., Belamarich, P. F., Tom-Revzon, C. (2007). The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions. Pediatrics 119: 370-380 [Abstract] [Full Text]  
• Katan, M. B (2006). Reply to U Ravnskov. Am. J. Clin. Nutr. 84: 1551-1552 [Full Text]